These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35927399)

  • 1. Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans.
    Xu S; Carpenter MC; Spreng RL; Neidich SD; Sarkar S; Tenney D; Goodman D; Sawant S; Jha S; Dunn B; Juliana McElrath M; Bekker V; Mudrak SV; Flinko R; Lewis GK; Ferrari G; Tomaras GD; Shen X; Ackerman ME
    NPJ Vaccines; 2022 Aug; 7(1):90. PubMed ID: 35927399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.
    McGuire EP; Fong Y; Toote C; Cunningham CK; McFarland EJ; Borkowsky W; Barnett S; Itell HL; Kumar A; Gray G; McElrath MJ; Tomaras GD; Permar SR; Fouda GG
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29021402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
    Laher F; Moodie Z; Cohen KW; Grunenberg N; Bekker LG; Allen M; Frahm N; Yates NL; Morris L; Malahleha M; Mngadi K; Daniels B; Innes C; Saunders K; Grant S; Yu C; Gilbert PB; Phogat S; DiazGranados CA; Koutsoukos M; Van Der Meeren O; Bentley C; Mkhize NN; Pensiero MN; Mehra VL; Kublin JG; Corey L; Montefiori DC; Gray GE; McElrath MJ; Tomaras GD
    PLoS Med; 2020 Feb; 17(2):e1003038. PubMed ID: 32092060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.
    Gray GE; Huang Y; Grunenberg N; Laher F; Roux S; Andersen-Nissen E; De Rosa SC; Flach B; Randhawa AK; Jensen R; Swann EM; Bekker LG; Innes C; Lazarus E; Morris L; Mkhize NN; Ferrari G; Montefiori DC; Shen X; Sawant S; Yates N; Hural J; Isaacs A; Phogat S; DiazGranados CA; Lee C; Sinangil F; Michael NL; Robb ML; Kublin JG; Gilbert PB; McElrath MJ; Tomaras GD; Corey L
    Sci Transl Med; 2019 Sep; 11(510):. PubMed ID: 31534016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
    Moodie Z; Andersen-Nissen E; Grunenberg N; Dintwe OB; Omar FL; Kee JJ; Bekker LG; Laher F; Naicker N; Jani I; Mgodi NM; Hunidzarira P; Sebe M; Miner MD; Polakowski L; Ramirez S; Nebergall M; Takuva S; Sikhosana L; Heptinstall J; Seaton KE; De Rosa S; Diazgranados CA; Koutsoukos M; Van Der Meeren O; Barnett SW; Kanesa-Thasan N; Kublin JG; Tomaras GD; McElrath MJ; Corey L; Mngadi K; Goepfert P;
    PLoS Med; 2024 Mar; 21(3):e1004360. PubMed ID: 38502656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans.
    Zhao LP; Fiore-Gartland A; Carpp LN; Cohen KW; Rouphael N; Fleurs L; Dintwe O; Zhao M; Moodie Z; Fong Y; Garrett N; Huang Y; Innes C; Janes HE; Lazarus E; Michael NL; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Robb ML; De Rosa SC; Corey L; Gray GE; Seaton KE; Yates NL; McElrath MJ; Frahm N; Tomaras GD; Gilbert PB
    PLoS One; 2020; 15(1):e0226803. PubMed ID: 31999736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response.
    Williams LD; Shen X; Sawant SS; Akapirat S; Dahora LC; Tay MZ; Stanfield-Oakley S; Wills S; Goodman D; Tenney D; Spreng RL; Zhang L; Yates NL; Montefiori DC; Eller MA; Easterhoff D; Hope TJ; Rerks-Ngarm S; Pittisuttithum P; Nitayaphan S; Excler JL; Kim JH; Michael NL; Robb ML; O'Connell RJ; Karasavvas N; Vasan S; Ferrari G; Tomaras GD;
    PLoS Pathog; 2023 May; 19(5):e1011359. PubMed ID: 37256916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41.
    Duchemin M; Tudor D; Cottignies-Calamarte A; Bomsel M
    Front Immunol; 2020; 11():1141. PubMed ID: 32582208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of T
    Verma A; Schmidt BA; Elizaldi SR; Nguyen NK; Walter KA; Beck Z; Trinh HV; Dinasarapu AR; Lakshmanappa YS; Rane NN; Matyas GR; Rao M; Shen X; Tomaras GD; LaBranche CC; Reimann KA; Foehl DH; Gach JS; Forthal DN; Kozlowski PA; Amara RR; Iyer SS
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31827000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques.
    Phillips B; Van Rompay KKA; Rodriguez-Nieves J; Lorin C; Koutsoukos M; Tomai M; Fox CB; Eudailey J; Dennis M; Alam SM; Hudgens M; Fouda G; Pollara J; Moody A; Shen X; Ferrari G; Permar S; De Paris K
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions.
    Sherburn R; Tolbert WD; Gottumukkala S; Hederman AP; Beaudoin-Bussières G; Stanfield-Oakley S; Tuyishime M; Ferrari G; Finzi A; Ackerman ME; Pazgier M
    Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Heterologous Simian Immunodeficiency Virus SIV
    Singh S; Ramírez-Salazar EG; Doueiri R; Valentin A; Rosati M; Hu X; Keele BF; Shen X; Tomaras GD; Ferrari G; LaBranche C; Montefiori DC; Das J; Alter G; Trinh HV; Hamlin C; Rao M; Dayton F; Bear J; Chowdhury B; Alicea C; Lifson JD; Broderick KE; Sardesai NY; Sivananthan SJ; Fox CB; Reed SG; Venzon DJ; Hirsch VM; Pavlakis GN; Felber BK
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
    Buchbinder SP; Grunenberg NA; Sanchez BJ; Seaton KE; Ferrari G; Moody MA; Frahm N; Montefiori DC; Hay CM; Goepfert PA; Baden LR; Robinson HL; Yu X; Gilbert PB; McElrath MJ; Huang Y; Tomaras GD;
    PLoS One; 2017; 12(7):e0179597. PubMed ID: 28727817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.
    Pollara J; Jones DI; Huffman T; Edwards RW; Dennis M; Li SH; Jha S; Goodman D; Kumar A; LaBranche CC; Montefiori DC; Fouda GG; Hope TJ; Tomaras GD; Staats HF; Ferrari G; Permar SR
    J Virol; 2019 May; 93(10):. PubMed ID: 30842326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01
    Van Der Meeren O; Jongert E; Seaton KE; Koutsoukos M; Aerssens A; Brackett C; Debois M; Janssens M; Leroux-Roels G; Mesia Vela D; Sawant S; Yates NL; Tomaras GD; Leroux-Roels I; Roman F
    Vaccine; 2020 Feb; 38(7):1678-1689. PubMed ID: 31932137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.
    Shen X; Basu R; Sawant S; Beaumont D; Kwa SF; LaBranche C; Seaton KE; Yates NL; Montefiori DC; Ferrari G; Wyatt LS; Moss B; Alam SM; Haynes BF; Tomaras GD; Robinson HL
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29021394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection.
    Curtis AD; Saha PT; Dennis M; Berendam SJ; Ramasubramanian P; Cross KA; Alam SM; Ferrari G; Kozlowski PA; Fouda GG; Hudgens MG; Van Rompay KKA; Pollara J; Permar SR; De Paris K
    mSphere; 2022 Feb; 7(1):e0083921. PubMed ID: 35196125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.
    Neidich SD; Fong Y; Li SS; Geraghty DE; Williamson BD; Young WC; Goodman D; Seaton KE; Shen X; Sawant S; Zhang L; deCamp AC; Blette BS; Shao M; Yates NL; Feely F; Pyo CW; Ferrari G; ; Frank I; Karuna ST; Swann EM; Mascola JR; Graham BS; Hammer SM; Sobieszczyk ME; Corey L; Janes HE; McElrath MJ; Gottardo R; Gilbert PB; Tomaras GD
    J Clin Invest; 2019 Nov; 129(11):4838-4849. PubMed ID: 31589165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
    Bekker LG; Moodie Z; Grunenberg N; Laher F; Tomaras GD; Cohen KW; Allen M; Malahleha M; Mngadi K; Daniels B; Innes C; Bentley C; Frahm N; Morris DE; Morris L; Mkhize NN; Montefiori DC; Sarzotti-Kelsoe M; Grant S; Yu C; Mehra VL; Pensiero MN; Phogat S; DiazGranados CA; Barnett SW; Kanesa-Thasan N; Koutsoukos M; Michael NL; Robb ML; Kublin JG; Gilbert PB; Corey L; Gray GE; McElrath MJ;
    Lancet HIV; 2018 Jul; 5(7):e366-e378. PubMed ID: 29898870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.